MMA Embolization for Refractory Chronic Migraine

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 23, 2025

Primary Completion Date

December 25, 2028

Study Completion Date

December 29, 2028

Conditions
Migraine
Interventions
DEVICE

Middle Meningeal Artery embolization

Bilateral middle meningeal artery embolization using TRUFILL n-BCA liquid embolic system

Trial Locations (5)

10029

NOT_YET_RECRUITING

Mount Sinai, New York

11794

RECRUITING

Stony Brook University Medical Center, Stony Brook

19107

NOT_YET_RECRUITING

Thomas Jefferson University Hospital, Philadelphia

26506

RECRUITING

West Virginia University, Morgantown

38120

RECRUITING

Semmes Murphey Foundation, Memphis

All Listed Sponsors
lead

Cerenovus, Part of DePuy Synthes Products, Inc.

INDUSTRY

NCT06735833 - MMA Embolization for Refractory Chronic Migraine | Biotech Hunter | Biotech Hunter